QUOTE(N30SS @ Jul 20 2006, 05:25 PM) [snapback]634578[/snapback]
This might be of more interest to you medigrowers but does anybody know of "simm 18" and bedrocan? Heard thats what they use as real medical cannabis in holland, anybody know what they are bred from? they are supposed to be very uniform in taste and potency.????
i beleive the simm18 was grown in holland under a program for the dutch ministry of health.
it was given out(not sure in what form) to medical suffers who rejected it because of lack of potency.these medi buyers,then went to the coffee shops and at present,the commercial grower is facing ruin.
bedrocan is the latest medi grower to suceed simm.
i beleive these weeds are specifically grown and tuned towards high cbd levels.
quote
So what went wrong? Burton agrees with Fvanhoorn: price and quality. The latter - at least for medicinal users - is determined by levels of cannabinoids in the plants. These are compounds that react with receptors in the brain that control pain and mood. Varieties of cannabis have more than 60 different cannabinoids, but the two that seem to help MS, cancer and glaucoma sufferers most are tetrahydrocannabinol (THC) and cannabidiol (CBD).
Burton claims that when the Government had his plants tested before deciding which he should grow for the programme, the testing was flawed. The company testing for the Government, Dutch-based TNO, one of Europe's biggest analytical research organisations, reported that one of his strains, SIMM 18, contained 13 per cent THC and 8 per cent CBD.
"We can produce much higher levels of THC, but 8 per cent CBD was very high indeed," says Burton."CBD is thought to act as a muscle relaxant, but it hasn't got the psychoactive effects of THC; it doesn't make you high. So for MS sufferers, this was going to be fantastic.The Government told us to grow that one; we signed a five-year contract and began producing. "
Subsequent tests, after Burton had committed himself to producing for five years, showed that the actual level of CBD in SIMM 18 was only 0.7 per cent. TNO said this week that no one was available to discuss Burton's allegations, but he has put the company on notice that he plans to sue.